Hoya Corporation acquired 100% stakes in Mid Labs and Fritz Ruck Ophalmologische.

HOYA Surgical Optics, the intraocular lens and related products division of HOYA Group, acquired two medical device companies: US-based Mid Labs and Germany-based Fritz Ruck. Financial terms were not disclosed. Mid Labs is a California- based company focused on the research, innovation, development, engineering and manufacturing of ophthalmic medical surgical devices used to prevent blindness caused by certain retinal diseases and traumatic injuries. Fritz Ruck is based in Eschweiler, Germany, and manufactures dual function phacoemulsification machines and accessories as well as distributes other ophthalmic devices and instruments. This acquisition will help to broaden HOYA Surgical Optics’ product portfolio and enable HSO to better serve our customers’ broader needs for high quality ophthalmic products, equipment and services. Through this, HOYA Surgical Optics aims to accelerate the growth of IOL sales and further solidify accelerating the growth of IOL sales and further solidify its position as the fastest growing IOL company globally. “HOYA Surgical Optics is currently the fastest growing IOL company in the world and 3rd largest in terms of IOL value. We are one of the leading medical device companies that contributes towards the treatment of cataract and other leading causes of blindness worldwide. The acquisition will expand HOYA Surgical Optics’ technology portfolio in surgical ophthalmology to encompass a very attractive and competitive offering within cataract surgery. It will also allow us to provide superior solutions for treatment of the retinal and posterior segment diseases," John Goltermann Lassen, HOYA Surgical Optics CEO.